DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Emend (Aprepitant) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Emend (Aprepitant) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (205)
Death (31)
Life Threatening Events (24)
Disability (2)

Reports by Reaction Type

Nausea (24)Dyspnoea (18)Encephalopathy (18)Drug Interaction (16)Renal Failure Acute (14)Vomiting (9)Convulsion (9)Dehydration (9)Neutropenia (9)Septic Shock (9)Dermatitis Bullous (8)Renal Failure (8)

Below are a few examples of reports where side effects / adverse reactions may be related to Emend (Aprepitant). For a complete list or a specific selection of reports, please use the links above.

Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-27

Patient:

Reactions: Drug Hypersensitivity

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Infusion Related Reaction, Infusion Site Erythema

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Headache

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23

Patient:

Reactions: Cardio-Respiratory Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Start date: 2012-02-21
    End date: 2012-02-21

Emend
    Dosage: 80 mg, once
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-02-22

Etoposide
    Dosage: 200 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Methylprednisolone
    Dosage: 160 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Methylprednisolone
    Dosage: 60 mg, once
    Start date: 2012-02-21
    End date: 2012-02-21

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-02-21
    End date: 2012-02-21

Ondansetron
    Dosage: 8 mg, once
    Start date: 2012-02-22
    End date: 2012-02-22

Other drugs received by patient: Bicnu; Diamicron; Pravastatin Sodium; Amlodipine; Valium; Nexium; Tramadol HCL; Acetaminophen



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Incorrect Route of Drug Administration, NO Adverse Event

Drug(s) suspected as cause:
Emend
    Dosage: unk
    Indication: Nausea
    Start date: 2012-08-09

Emend
    Indication: Vomiting



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Capsule Physical Issue, NO Adverse Event, Drug Administration Error

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Stomatitis, Anaemia, Febrile Neutropenia, Constipation, Neutrophil Count Decreased

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 700 mg, qd
    Start date: 2010-10-26
    End date: 2010-10-26

Cyclophosphamide
    Dosage: 700 mg, qd
    Start date: 2010-12-07
    End date: 2010-12-07

Cyclophosphamide
    Dosage: 700 mg, qd
    Start date: 2010-11-16
    End date: 2010-11-16

Cyclophosphamide
    Dosage: 700 mg, once
    Indication: Breast Cancer
    Start date: 2010-09-29
    End date: 2010-10-29

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-10-27
    End date: 2010-10-28

Emend
    Dosage: 125 mg, qd
    Administration route: Oral
    Start date: 2010-12-07
    End date: 2010-12-07

Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2010-09-29
    End date: 2010-09-29

Emend
    Dosage: 125 mg, qd
    Administration route: Oral
    Start date: 2010-10-26
    End date: 2010-10-26

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-09-30
    End date: 2010-10-01

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-12-08
    End date: 2010-12-09

Emend
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2010-11-17
    End date: 2010-11-18

Emend
    Dosage: 125 mg, qd
    Administration route: Oral
    Start date: 2010-11-16
    End date: 2010-11-16

Epirubicin Hydrochloride
    Dosage: |100 mg, once
    Indication: Breast Cancer
    Start date: 2010-09-29
    End date: 2010-09-29

Epirubicin Hydrochloride
    Dosage: 100 mg, qd
    Start date: 2010-12-07
    End date: 2010-12-07

Epirubicin Hydrochloride
    Dosage: 100 mg, qd
    Start date: 2010-10-26
    End date: 2010-10-26

Epirubicin Hydrochloride
    Dosage: 100 mg, qd
    Start date: 2010-11-16
    End date: 2010-11-16

Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Granisetron Hydrochloride; Mucosta; Mucosta; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate



Possible Emend side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Drug Ineffective, Nausea

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Carboplatin; Compazine; Gemzar



Possible Emend side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Adverse Event

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Cerebrovascular Accident

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Dyspnoea, Chest Pain

Drug(s) suspected as cause:
Emend
    Dosage: 150 mg, once
    Start date: 2012-05-03

Emend
    Dosage: 150 mg, once
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-05-24

Other drugs received by patient: Taxol; Taxol; Cisplatin; Cisplatin



Possible Emend side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Convulsion

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Dexamethasone; TAC; Zofran



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-22

Patient:

Reactions: Infusion Site Pain

Drug(s) suspected as cause:
Emend



Possible Emend side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
Emend



Possible Emend side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-14

Patient: 67 year old male

Reactions: Electrocardiogram QT Prolonged, Cardio-Respiratory Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, single
    Indication: B-Cell Lymphoma
    Start date: 2012-02-22
    End date: 2012-02-22

Emend
    Dosage: 80 mg, 1x/day
    Administration route: Oral
    Indication: Premedication
    Start date: 2012-02-21
    End date: 2012-02-22

Etoposide
    Dosage: 100 mg/m2, single
    Indication: B-Cell Lymphoma
    Start date: 2012-02-22
    End date: 2012-02-22

Methylprednisolone
    Dosage: 160 mg, 1x/day
    Indication: Premedication
    Start date: 2012-02-21
    End date: 2012-02-22

Ondansetron
    Dosage: 8 mg, 1x/day
    Indication: Premedication
    Start date: 2012-02-21
    End date: 2012-02-22

Other drugs received by patient: Diamicron; Amlodipine; Acetaminophen; Bicnu; Nexium; Pravastatin; Valium; Tramadol HCL



Possible Emend side effects in

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Ondansetron; Adriamycin PFS; Dexamethasone; Dexamethasone; Cisplatin



Possible Emend side effects in 50 year old male

Reported by a physician from Japan on 2012-08-13

Patient: 50 year old male

Reactions: Schizophrenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Decadron Phosphate
    Dosage: dosage is uncertain.
    Indication: Product Used FOR Unknown Indication

Emend
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Herbal Nerve Tonic Liquid
    Dosage: dosage is uncertain.
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Magnesium Oxide
    Dosage: dosage is uncertain, drug reported as : ju-kama
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Oxaliplatin
    Dosage: dosage is uncertain.
    Indication: Large Intestine Carcinoma

Xeloda
    Administration route: Oral
    Indication: Large Intestine Carcinoma



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-08-10

Patient:

Reactions: Vomiting, Nausea

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Emend
    Administration route: Oral
    Indication: Nausea

Emend
    Indication: Vomiting



Possible Emend side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08

Patient: female, weighing 68.0 kg (149.6 pounds)

Reactions: Chest Discomfort, Paraesthesia Oral, Nausea, Tachycardia, Erythema, Anxiety, Feeling Hot, Infusion Related Reaction

Drug(s) suspected as cause:
Emend
    Dosage: 150mg in 145ml of ns once iv
    Indication: Bladder Adenocarcinoma Stage Unspecified
    Start date: 2012-08-06
    End date: 2012-08-06

Emend
    Dosage: 150mg in 145ml of ns once iv
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-08-06
    End date: 2012-08-06

Other drugs received by patient: NS; Potassium; Magnesium



Possible Emend side effects in

Reported by a physician from Czech Republic on 2012-08-07

Patient:

Reactions: Acute Psychosis

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Ifosfamide; Corticosteroids (Unspecified)



Possible Emend side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: female, weighing 54.5 kg (119.9 pounds)

Reactions: Off Label Use, Cerebrovascular Accident, Disability

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Dronabinol
    Indication: Impaired Gastric Emptying

Dronabinol
    Indication: Nausea
    Start date: 2008-01-01

Dronabinol
    Indication: Vomiting

Emend
    Indication: Nausea

Emend
    Indication: Impaired Gastric Emptying

Emend
    Indication: Vomiting
    Start date: 2008-01-01



Possible Emend side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: female, weighing 54.5 kg (119.9 pounds)

Reactions: Off Label Use, Cerebrovascular Accident, Disability

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Dronabinol
    Indication: Impaired Gastric Emptying

Dronabinol
    Indication: Nausea
    Start date: 2008-01-01

Dronabinol
    Indication: Vomiting

Emend
    Indication: Vomiting

Emend
    Indication: Impaired Gastric Emptying

Emend
    Indication: Nausea
    Start date: 2008-01-01



Possible Emend side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient:

Reactions: Pain in Extremity, Infusion Site Pain, Infusion Site Rash, Infusion Site Pruritus

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Doxorubicin Hydrochloride



Possible Emend side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient:

Reactions: Pain in Extremity, Infusion Site Pain, Infusion Site Rash, Infusion Site Pruritus

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Doxorubicin Hydrochloride



Possible Emend side effects in

Reported by a physician from Czech Republic on 2012-08-01

Patient:

Reactions: Acute Psychosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Emend
    Dosage: 125 mg, once
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-06-20

Emend
    Dosage: 80 mg, once
    Administration route: Oral
    Start date: 2012-06-21

Emend
    Dosage: 80 mg, once
    Administration route: Oral
    Start date: 2012-06-22

Other drugs received by patient: Doxorubicin Hydrochloride; Mesna; Mesna; Fraxiparine; Dexona Injection; Metoprolol Tartrate; Fraxiparine; Corticosteroids (Unspecified); Oxycontin; Ondansetron; Cordarone; Potassium Chloride; Mesna; Ifosfamide



Possible Emend side effects in

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient:

Reactions: Pain in Extremity, Infusion Site Pain, Infusion Site Rash, Infusion Site Pruritus

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Doxorubicin Hydrochloride



Possible Emend side effects in

Reported by a physician from France on 2012-08-01

Patient:

Reactions: Renal Failure, Lung Disorder, Toxic Encephalopathy, Drug Interaction, Pancytopenia, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Emend

Other drugs received by patient possibly interacting with the suspect drug:
Cyclophosphamide
    Dosage: unk
    Indication: Sarcoma
    Start date: 2012-03-22

Cyclophosphamide
    Dosage: unk
    Start date: 2012-04-23

Cyclophosphamide
    Dosage: unk

Other drugs received by patient: Calciparine; Granocyte; Zofran



Possible Emend side effects in

Reported by a physician from Czech Republic on 2012-07-31

Patient:

Reactions: Acute Psychosis

Drug(s) suspected as cause:
Emend

Other drugs received by patient: Corticosteroids (Unspecified)



Possible Emend side effects in

Reported by a pharmacist from United States on 2012-07-31

Patient:

Reactions: Pain, Adverse Event, Skin Burning Sensation

Drug(s) suspected as cause:
Emend

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017